Ahead Therapeutics is a biotech company that specializes in the treatments for auto-immune disorders. The company develops a solution based on the use of PS-liposomes containing auto-autoantigens. Its technology, based on bio-mimicking efferocytosis, can address the treatment of diseases such as type 1 diabetes, multiple sclerosis, and celiac diseases by changing the encapsulated auto-antigen.